2003
DOI: 10.1161/01.atv.0000090570.99836.9c
|View full text |Cite
|
Sign up to set email alerts
|

Oxidized HDL

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
9
0

Year Published

2004
2004
2022
2022

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(10 citation statements)
references
References 30 publications
1
9
0
Order By: Relevance
“…In an accompanying editorial, Bergt, Oram, and Heinecke (112) suggested that cross-linked heterodimers of apoA-I and apoA-II in tyrosylated HDL may be responsible for its enhanced ability to remove cholesterol from lipidladen cells (113). These authors (112) speculated that heterodimers may act more like lipid-free apolipoproteins, perhaps because of conformational changes in apoA-I that expose more amphipathic ␣ -helices to ABCA1.…”
Section: Figurementioning
confidence: 99%
See 3 more Smart Citations
“…In an accompanying editorial, Bergt, Oram, and Heinecke (112) suggested that cross-linked heterodimers of apoA-I and apoA-II in tyrosylated HDL may be responsible for its enhanced ability to remove cholesterol from lipidladen cells (113). These authors (112) speculated that heterodimers may act more like lipid-free apolipoproteins, perhaps because of conformational changes in apoA-I that expose more amphipathic ␣ -helices to ABCA1.…”
Section: Figurementioning
confidence: 99%
“…These authors (112) speculated that heterodimers may act more like lipid-free apolipoproteins, perhaps because of conformational changes in apoA-I that expose more amphipathic ␣ -helices to ABCA1. They also noted that apoA-I mimetic peptides synthesized from d -amino acids appear to retard atherogenesis in hypercholesterolemic mice without affecting HDL levels and that in vitro studies have suggested that this effect is mediated in part by inhibition of LDL oxidation (87).…”
Section: Figurementioning
confidence: 99%
See 2 more Smart Citations
“…4-10 At the same time, failure of antioxidants such as vitamin E to protect against atherosclerosis in clinical trials, together with growing evidence that the anti-atherogenic action of the lipid-lowering drug probucol is not related to its antioxidant effects 11 and the notion that such cardioprotective activities as exercise or red wine consumption are pro-oxidant, suggest that not all forms of oxidized lipoproteins are atherogenic. 9,12 Although the central role of LDL oxidation in atherogenesis is widely accepted 9 , the role of HDL oxidation remains contested. Oxidation is generally thought to impair atheroprotective functions of HDL (13 -18 and references therein).…”
Section: Introductionmentioning
confidence: 99%